載入...
Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients
The rapid advancement in the development of therapeutic proteins, including monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), has created a novel mechanism to selectively deliver highly potent cytotoxic agents in the treatment of cancer. These agents provide numerous benefits compare...
Na minha lista:
| 發表在: | Antibodies (Basel) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640706/ https://ncbi.nlm.nih.gov/pubmed/31544809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib8010003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|